Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    PRQR Gross Margin

    As of 2025-07-09, the Gross Margin of ProQR Therapeutics NV (PRQR) is 7775.2%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    PRQR Gross Margin - Historical Value
    DateValue
    2024-12-31 7775.2%
    2023-12-31 -
    2022-12-31 -
    2021-12-31 -
    2020-12-31 -
    2019-12-31 -
    2018-12-31 -
    2017-12-31 -
    2016-12-31 -
    2015-12-31 -
    PRQR Gross Margin - Peers Comparison
    TickerNameValue
    ABUSArbutus Biopharma Corp7775.2%
    ARGX.BRargenx SE92.8%
    BIVIBioVie Inc7775.2%
    CBMGCellular Biomedicine Group Inc81.6%
    CMPICheckmate Pharmaceuticals Inc-
    CRDFCardiff Oncology Inc100%
    CUECue Biopharma Inc7775.2%
    DBTXDecibel Therapeutics Inc7775.2%
    EIGREiger BioPharmaceuticals Inc99.9%
    ESP.ASEsperite NV65.8%
    FBRXForte Biosciences Inc7775.2%
    GRTXGalera Therapeutics Inc7775.2%
    IBIOiBio Inc38.4%
    IMNMImmunome Inc7775.2%
    IMUXImmunic Inc7775.2%
    KDS.ASKiadis Pharma NV-
    KZRKezar Life Sciences Inc7775.2%
    LCTXLineage Cell Therapeutics Inc96.5%
    LRMRLarimar Therapeutics Inc7775.2%
    MNOVMediciNova Inc100%
    MRUSMerus NV7775.2%
    NCNANuCana PLC7775.2%
    NXTCNextCure Inc7775.2%
    ONCROncorus Inc7775.2%
    OVIDOvid Therapeutics Inc7775.2%
    PHARM.ASPharming Group NV88.1%
    QUREUniqure NV32.4%
    SQZSQZ Biotechnologies Co7775.2%
    TRVNTrevena Inc46.6%
    TYMETyme Technologies Inc-
    UBXUNITY Biotechnology Inc7775.2%
    VINCVincerx Pharma Inc7775.2%
    VTGNVistagen Therapeutics Inc7775.2%
    XOMAXOMA Corp100%
    Tickers added to watchlist